Quote:From Mayomobile posted on Stocktwits: considering the awarding of 10s of thousands of shares to board members after hours, I would say it is like the Phase 2b/3 AD trial just concluded. Clinical trials website shows estimated completion date of the trial was tentatively 30 June 2022. Here we go.. Anyone care to comment ???????
Suggests good news A.M., my guess. Many people WW need CNS diseases good news, bless them all.